Pet Health
Plasma Cell Tumor in Dogs: What to Know and Where to Start
A plasma cell tumor in dogs is an abnormal growth of immune cells, usually found in the skin, that is often successfully treated with surgical removal.
Key takeaways
A plasma cell tumor in dogs is an abnormal growth of immune cells, usually found in the skin, that is often successfully treated with surgical removal.
- Plasma cell tumors, also called plasmacytomas, most commonly affect middle-aged and older dogs.
- They frequently appear as small, raised, pink or red lumps on the head, ears, lips, or legs.
- Most skin plasmacytomas are benign and remain localized, although tumors in other locations can behave differently.
- A veterinarian can identify the growth through microscopic examination of cells or tissue.
- The appropriate treatment depends on the tumor's location, diagnosis, and whether it has affected surrounding tissues.
What Is a Plasma Cell Tumor in Dogs?
A plasma cell tumor develops when plasma cells multiply abnormally and form a mass.
Plasma cells are specialized immune cells that produce antibodies to help the body respond to infections and other foreign substances.
A canine plasma cell tumor is also called a plasmacytoma. These tumors belong to a group of growths known as round cell tumors because their cells have a characteristic rounded appearance under a microscope.
The main forms of plasma cell tumors include:
• Cutaneous plasmacytoma: A tumor that develops in the skin, commonly on the head, ears, lips, legs, or trunk.
• Oral plasmacytoma: A growth involving tissues inside the mouth, including the gums, tongue, or palate.
• Gastrointestinal plasmacytoma: A tumor that develops within the digestive tract.
• Solitary osseous plasmacytoma: An uncommon plasma cell tumor involving bone.
Skin and oral plasmacytomas generally have favorable outcomes when completely removed. Gastrointestinal and bone tumors require additional evaluation because their behavior and treatment needs can differ.
Plasma cell tumors are also related to multiple myeloma, a cancer involving plasma cells in the bone marrow. Multiple myeloma is a separate, systemic condition rather than the usual diagnosis for a dog with an isolated skin plasmacytoma.
The diagnosis of plasmacytoma therefore describes the cells involved, while the tumor's location and extent help determine the treatment plan.
Why Plasma Cell Tumors Develop
Plasma cell tumors form when changes within plasma cells cause uncontrolled cell growth.
The precise trigger for most canine plasmacytomas is unknown.
The development of a tumor involves abnormal cellular behavior rather than the normal production of antibodies. These altered cells accumulate in a particular tissue and eventually create a visible or detectable mass.
Age is an important risk factor. Plasma cell tumors are diagnosed most often in mature and senior dogs, although they can occur outside those age groups.
Certain breeds also appear more likely to develop plasmacytomas. Breeds reported with increased risk include:
• Cocker Spaniels
• Airedale Terriers
• Scottish Terriers
• Standard Poodles
• Yorkshire Terriers
• Boxers
• West Highland White Terriers
Breed predisposition indicates increased susceptibility, not that a dog will necessarily develop a tumor.
Research has not established a single preventable cause of canine plasmacytomas. The condition is not reliably linked to a particular food, grooming product, or routine activity.
Some tumors contain deposits of amyloid, a protein material that can accumulate around abnormal plasma cells. Amyloid deposits have been associated with recurrence in some cases.
Because the exact causes are poorly understood, routine skin checks and veterinary evaluation of new lumps are more practical than attempting to prevent plasmacytomas through unproven products or treatments.
What a Plasma Cell Tumor Looks Like
A cutaneous plasma cell tumor usually appears as a small, raised, rounded growth.
Its surface is often smooth, pink or reddish, and partially or completely hairless.
The tumor may resemble a button sitting on the skin. Some growths have a broader base, while others protrude from the surface on a narrower attachment.
Common physical characteristics include a firm or soft texture, clearly defined edges, and a smooth or slightly irregular surface.
Skin plasmacytomas frequently develop around the head and extremities. A dog might develop a growth on an ear flap, along the lip, on a leg, or near a toe.
The location influences the symptoms.
On the skin: A tumor may be noticed during grooming or petting. Some growths become irritated or ulcerated, creating a sore that occasionally bleeds.
On a paw or toe: The growth may interfere with walking if it becomes painful or repeatedly contacts the ground.
Inside the mouth: An oral plasmacytoma may cause difficulty chewing, drooling, bleeding, or discomfort while eating.
In the digestive tract: Gastrointestinal tumors may produce vomiting, diarrhea, blood in the stool, reduced appetite, or weight loss.
Within bone: A solitary bone plasmacytoma may cause pain, lameness, or difficulty moving. Tumors affecting the spine may produce neurological symptoms.
Many dogs with an isolated skin plasmacytoma otherwise behave normally and maintain their usual appetite and activity.
Similar-looking lumps can develop from histiocytomas, mast cell tumors, and other skin conditions, so appearance alone cannot confirm a plasma cell tumor.
Risks, Prognosis, and Possible Complications
Most solitary cutaneous plasmacytomas in dogs have a favorable prognosis.
They generally remain localized, and surgical removal is often sufficient treatment.
Published veterinary studies summarized in a clinical review report local recurrence rates below 5% for cutaneous plasmacytomas treated surgically.
The outlook changes according to the tumor's location, extent, and biological behavior.
Local recurrence
A plasmacytoma can return after treatment, particularly when local disease is difficult to control.
Oral plasmacytomas can present additional surgical challenges because the surrounding tissues limit how much material can be removed.
A returning lump requires reassessment to distinguish tumor recurrence from scar tissue, inflammation, or another growth.
Multiple skin tumors
Some dogs develop several plasma cell tumors rather than an isolated mass.
A condition called cutaneous plasmacytosis involves multiple cutaneous plasma cell tumors without an established diagnosis of multiple myeloma.
This uncommon presentation can behave more aggressively than a solitary skin plasmacytoma. Additional testing helps determine whether lymph nodes, bone marrow, or other tissues are involved.
Internal tumors and systemic disease
Gastrointestinal plasmacytomas have a more variable prognosis. Tumors involving the colon or rectum often respond favorably to complete removal, while tumors elsewhere in the digestive tract can behave more aggressively.
Solitary bone plasmacytomas can damage surrounding bone and sometimes progress despite local treatment.
Multiple myeloma may produce additional problems involving the bones, kidneys, blood proteins, or blood clotting.
Dogs with unexplained weakness, significant weight loss, bone pain, abnormal bleeding, or multiple tumors require a broader evaluation than dogs with an uncomplicated solitary skin growth.
How Veterinarians Diagnose Plasma Cell Tumors
Diagnosis begins with examining the lump and collecting information about its development.
The veterinarian assesses its location, size, texture, appearance, and attachment to surrounding tissues. The examination may also include nearby lymph nodes and a search for additional masses.
Microscopic testing is the main method used to identify plasma cell tumors.
Fine-needle aspiration and cytology
Fine-needle aspiration is a common initial diagnostic procedure.
A small needle collects cells from the lump. The collected material is placed on a microscope slide and examined through a process called cytology.
Plasma cell tumor dog cytology typically reveals distinctive cellular features, including:
• Round cells that appear individually rather than forming tightly connected clusters.
• Nuclei frequently positioned toward the edge of the cell.
• Deep blue or purple-staining cytoplasm.
• A pale area near the nucleus called the perinuclear Golgi zone.
• Coarsely clumped material inside the nucleus.
• Occasional cells containing multiple nuclei.
These findings can support a diagnosis of plasmacytoma.
Some benign plasma cell tumors display substantial variation in cell size and appearance. Such changes can resemble features associated with more aggressive tumors.
Veterinary pathologists interpret the overall cell population rather than relying on an isolated unusual-looking cell.
Biopsy and histopathology
When cytology does not provide a clear answer, a tissue biopsy may be necessary.
A biopsy collects part or all of the growth for laboratory examination. Histopathology allows the pathologist to evaluate the arrangement of cells within the tissue.
This examination can help confirm tumor identity, identify invasive growth, and assess whether surgical removal was complete.
Additional laboratory staining, called immunohistochemistry, may be used when the diagnosis remains uncertain.
Markers such as MUM1 and CD79a can support the identification of plasma cell tumors, although the pathologist must interpret them alongside other findings because some tumor types share markers.
Additional testing
Dogs with isolated, uncomplicated skin plasmacytomas generally do not require extensive cancer staging.
Broader testing is appropriate when several tumors are present, blood protein concentrations are abnormal, or symptoms suggest internal disease.
Possible investigations include blood counts, blood chemistry testing, urinalysis, diagnostic imaging, and serum protein electrophoresis.
In selected cases, sampling of lymph nodes or bone marrow helps investigate more widespread plasma cell disease.
Treatment Options and Follow-Up Care
Surgical removal is the preferred treatment for most solitary skin plasmacytomas.
The goal is to remove the mass while preserving healthy surrounding tissue. Many of these tumors are well-defined, allowing conservative surgical excision.
After surgery, the removed tissue can be submitted for histopathology to confirm the diagnosis and examine the surgical margins.
A pathology report describing clean margins indicates that tumor cells were not identified at the examined tissue edges. Tumor cells reaching the surgical edge indicate that some disease may remain.
The importance of the margin findings depends on the tumor's characteristics and location.
Surgery for accessible tumors
Small skin plasmacytomas are often treated with a relatively straightforward removal procedure.
The surgical approach depends on the dog's overall health, the tumor's size, and its location.
Growths near the lips, ears, toes, or other sensitive structures may require more detailed surgical planning.
Most dogs with successfully removed solitary cutaneous plasmacytomas do not require chemotherapy.
Radiation therapy
Radiation therapy may be considered when a tumor cannot be removed safely or when local disease remains after surgery.
It can be useful for selected oral tumors, recurrent tumors, or growths located near structures that make complete removal difficult.
Radiation is also a potential option for some tumors involving bone or other difficult locations.
A veterinary radiation oncologist determines whether treatment is appropriate based on the diagnosis, affected tissue, and treatment goals.
Chemotherapy and advanced treatment
Chemotherapy is not routine treatment for an isolated benign cutaneous plasmacytoma.
Systemic medication may be considered when plasma cell tumors are widespread, recur repeatedly, or involve more aggressive disease.
Treatment of multiple myeloma follows a different approach from treatment of a localized skin plasmacytoma.
A veterinary oncologist can evaluate the expected benefits, adverse effects, and monitoring requirements of systemic treatment.
Recovery and monitoring
Recovery after surgery includes protecting the incision, maintaining appropriate activity restrictions, and attending scheduled rechecks.
The veterinary team may recommend protective clothing or a recovery collar to prevent licking and scratching.
Follow-up examinations help identify wound complications or returning growths.
Owners can monitor the original treatment site and periodically examine other parts of the dog's skin. Photographing new lumps and recording changes in size or appearance provides useful information during future examinations.
Where to Get Veterinary Help
A general veterinary clinic is the appropriate starting point for a newly discovered skin lump.
Primary care veterinarians can examine the growth, perform fine-needle aspiration, arrange laboratory testing, and determine whether surgical treatment is suitable.
Veterinary diagnostic laboratories provide cytology and histopathology services that help confirm the tumor type.
More complicated cases may require referral to a specialist.
A board-certified veterinary surgeon may be helpful when the tumor affects a sensitive area or requires complicated removal. A veterinary oncologist can evaluate recurrent, multiple, invasive, or internal plasma cell tumors.
When arranging an appointment, provide a history of when the mass appeared, whether it has changed, and whether the dog has developed any additional symptoms.
Bring previous cytology reports, biopsy findings, imaging results, and treatment records when available.
For a confirmed diagnosis, ask your veterinarian whether surgical removal is appropriate, whether additional testing is needed, and what follow-up examinations should include.
Seek urgent veterinary care for uncontrolled bleeding, severe pain, breathing difficulty, or sudden inability to walk.
Frequently asked questions
Are plasma cell tumors contagious between dogs?
Plasma cell tumors are not contagious. They develop from abnormal growth of the dog's own plasma cells and cannot spread through ordinary contact with another animal. Other dogs in the household do not require isolation because of a plasmacytoma diagnosis.
Can a plasmacytoma disappear without treatment?
Cutaneous plasmacytomas generally do not disappear spontaneously in the way some canine histiocytomas can. Surgical removal is the standard treatment for an accessible, confirmed plasmacytoma. The decision to remove a growth also depends on its location, the dog's overall health, and whether it causes discomfort.
Does fine-needle aspiration require general anesthesia?
Fine-needle aspiration of an accessible skin lump often can be performed without general anesthesia. The procedure involves collecting cells using a small needle and typically causes only brief discomfort. Sedation may be appropriate for dogs that cannot remain still or when the tumor is located in a difficult or painful area.
Can routine blood tests detect a plasma cell tumor?
Routine blood tests cannot reliably identify an isolated skin plasmacytoma. Diagnosis usually requires cytology or examination of tumor tissue. Blood tests become more useful when investigating systemic disease, abnormal protein production, or health conditions that affect treatment planning.
Are plasma cell tumors and mast cell tumors the same?
Plasma cell tumors and mast cell tumors arise from different types of immune cells. Both can produce raised skin lumps and belong to the broader category of round cell tumors. Their potential behavior and recommended treatments differ, making microscopic diagnosis important before choosing a treatment.
Editorial standards
Who wrote this guide
Written by VetWayfinder Editorial Team.
Every factual statement is tied to a cited source listed below. Report an error through the corrections page.
Sources
Each source supports at least one factual statement in this guide.
